S&P 500   3,384.12 (+0.63%)
DOW   27,902.72 (+0.44%)
QQQ   281.55 (+1.34%)
AAPL   116.42 (+0.53%)
MSFT   212.55 (+1.06%)
FB   266.80 (+1.87%)
GOOGL   1,492.43 (+1.83%)
AMZN   3,196.89 (+1.53%)
TSLA   439.43 (+2.43%)
NVDA   542.05 (+0.15%)
BABA   291.38 (-0.88%)
CGC   14.15 (-1.19%)
MU   47.58 (+1.32%)
GE   6.15 (-1.28%)
AMD   83.69 (+2.07%)
T   28.54 (+0.11%)
F   6.72 (+0.90%)
ACB   4.65 (+0.00%)
GILD   62.90 (-0.46%)
NFLX   510.46 (+2.09%)
DIS   123.77 (-0.25%)
BA   167.85 (+1.57%)
BAC   24.03 (-0.25%)
S&P 500   3,384.12 (+0.63%)
DOW   27,902.72 (+0.44%)
QQQ   281.55 (+1.34%)
AAPL   116.42 (+0.53%)
MSFT   212.55 (+1.06%)
FB   266.80 (+1.87%)
GOOGL   1,492.43 (+1.83%)
AMZN   3,196.89 (+1.53%)
TSLA   439.43 (+2.43%)
NVDA   542.05 (+0.15%)
BABA   291.38 (-0.88%)
CGC   14.15 (-1.19%)
MU   47.58 (+1.32%)
GE   6.15 (-1.28%)
AMD   83.69 (+2.07%)
T   28.54 (+0.11%)
F   6.72 (+0.90%)
ACB   4.65 (+0.00%)
GILD   62.90 (-0.46%)
NFLX   510.46 (+2.09%)
DIS   123.77 (-0.25%)
BA   167.85 (+1.57%)
BAC   24.03 (-0.25%)
S&P 500   3,384.12 (+0.63%)
DOW   27,902.72 (+0.44%)
QQQ   281.55 (+1.34%)
AAPL   116.42 (+0.53%)
MSFT   212.55 (+1.06%)
FB   266.80 (+1.87%)
GOOGL   1,492.43 (+1.83%)
AMZN   3,196.89 (+1.53%)
TSLA   439.43 (+2.43%)
NVDA   542.05 (+0.15%)
BABA   291.38 (-0.88%)
CGC   14.15 (-1.19%)
MU   47.58 (+1.32%)
GE   6.15 (-1.28%)
AMD   83.69 (+2.07%)
T   28.54 (+0.11%)
F   6.72 (+0.90%)
ACB   4.65 (+0.00%)
GILD   62.90 (-0.46%)
NFLX   510.46 (+2.09%)
DIS   123.77 (-0.25%)
BA   167.85 (+1.57%)
BAC   24.03 (-0.25%)
S&P 500   3,384.12 (+0.63%)
DOW   27,902.72 (+0.44%)
QQQ   281.55 (+1.34%)
AAPL   116.42 (+0.53%)
MSFT   212.55 (+1.06%)
FB   266.80 (+1.87%)
GOOGL   1,492.43 (+1.83%)
AMZN   3,196.89 (+1.53%)
TSLA   439.43 (+2.43%)
NVDA   542.05 (+0.15%)
BABA   291.38 (-0.88%)
CGC   14.15 (-1.19%)
MU   47.58 (+1.32%)
GE   6.15 (-1.28%)
AMD   83.69 (+2.07%)
T   28.54 (+0.11%)
F   6.72 (+0.90%)
ACB   4.65 (+0.00%)
GILD   62.90 (-0.46%)
NFLX   510.46 (+2.09%)
DIS   123.77 (-0.25%)
BA   167.85 (+1.57%)
BAC   24.03 (-0.25%)
Log in
OTCMKTS:RSLS

Reshape Lifesciences Earnings Date, Estimates & History

$4.00
0.00 (0.00 %)
(As of 09/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$4.00
Now: $4.00
$4.00
50-Day Range
$2.61
MA: $3.77
$5.00
52-Week Range
$1.14
Now: $4.00
$14.25
VolumeN/A
Average Volume1,821 shs
Market Capitalization$22.35 million
P/E RatioN/A
Dividend YieldN/A
Beta1.9

Earnings

Reshape Lifesciences (OTCMKTS:RSLS) Earnings Information

Reshape Lifesciences last released its earnings results on August 13th, 2020. The medical device company reported ($0.52) earnings per share for the quarter, beating the consensus estimate of ($13,104.00) by $13,103.48. The company had revenue of $1.70 million for the quarter. Reshape Lifesciences has generated $0.00 earnings per share over the last year. Reshape Lifesciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 12th, 2020 based off prior year's report dates.

Reshape Lifesciences Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Reshape Lifesciences (OTCMKTS RSLS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/12/2020
(Estimated)
       
8/13/20206/30/2020($13,104.00)($0.52)($0.52)$1.70 millionN/A
5/14/2020Q1 2020($0.63)($0.63)$2.79 millionN/A
11/14/2019Q3 2019($17.36)$71.72$3.52 millionN/A
8/14/2019Q2 2019($0.84)($0.43)$4.45 millionN/A
5/20/2019Q1 2019($0.54)($0.54)$3.07 millionN/A
11/14/2018Q3 2018($27.46)($27.46)$0.35 millionN/A
8/14/2018Q2($250.60)($672.00)$7.71$0.65 millionTranscript
5/14/2018Q1 2018($756.00)($5.40)$0.95 millionN/A
4/2/2018Q4 2017($1,176.00)($0.67)$0.79 millionN/A
11/14/2017Q3($609.00)($2,226.00)($1.06)$0.36 millionN/A
8/8/2017Q2 2017($2,100.00)($1,911.00)($0.91)$0.20 million$0.09 millionListen
5/16/2017Q1 2017($1,323.00)($2,667.00)($1.27)$0.04 millionN/A
3/7/2017Q4 2016($924.00)($5,565.00)($2.65)$0.14 millionN/A
11/10/2016Q3 2016($1,050.00)($357.00)($0.17)$0.34 million$0.30 millionN/A
8/4/2016Q216($1,575.00)($1,029.00)($0.49)$0.19 million$0.28 millionN/A
5/5/2016Q1 2016($117,474.00)($120,414.00)($48.95)$0.14 million$0.07 millionN/A
2/17/2016Q315($1,890.00)($1,995.00)($0.95)$0.43 million$0.15 millionListen
11/9/2015Q3 2015($176,127.00)($88,074.00)($41.94)$0.17 million$0.06 millionN/A
8/6/2015Q215($210.00)($210.00)($1.50)$0.06 million$0.08 millionN/A
4/30/2015Q1 2015($198,156.00)($176,127.00)($62.90)N/A
2/18/2015Q414($210.00)($189.00)($1.35)Transcript
11/12/2014Q3 14($210.00)($168.00)($1.20)N/A
8/7/2014Q2($210.00)($231.00)($1.65)Listen
4/30/2014Q1 14($210.00)($210.00)($1.50)Transcript
2/12/2014Q4 2013($243,526.80)($243,526.80)($243,526.80)N/A
10/31/2013Q3 2013($221,388.00)($243,526.80)($243,526.80)Transcript
7/31/2013Q2 2013($287,804.30)($243,526.80)($243,526.80)Listen
5/1/2013Q1 2013($309,943.10)($309,943.10)($309,943.10)$0.10 millionTranscript
2/13/2013Q4 2012($294.00)($357.00)$0.36 millionN/A
10/24/2012Q3 2012($286,230.00)($308,238.00)($146.78)N/A
8/7/2012Q2 2012($330,246.00)($281,820.00)($134.20)N/A
4/24/2012Q1 2012($396,312.00)($336,861.00)($160.41)N/A
1/26/2012Q4 2011($462,357.00)($482,181.00)($229.61)N/A
10/20/2011Q3 2011($594,468.00)($570,234.00)($271.54)N/A
7/21/2011Q2 2011($528,402.00)($438,144.00)($208.64)N/A
1/27/2011Q4 2010($660,513.00)($759,591.00)($361.71)N/A
10/21/2010Q3 2010($1,034,796.00)($1,290,198.00)($614.38)N/A
7/22/2010Q2 2010($1,254,960.00)($597.60)N/A
4/21/2010Q1 2010($924,525.00)($1,452,822.00)($691.82)N/A
1/28/2010Q4 2009($2,773,575.00)($1,056,594.00)($503.14)N/A
10/23/2009Q3 2009($2,905,665.00)($5,269,803.00)($2,509.43)N/A
7/23/2009Q2 2009($2,905,665.00)($3,103,779.00)($786.17)N/A
4/23/2009Q1 2009($2,641,506.00)($3,975,468.00)($1,893.08)N/A
1/29/2009Q4 2008($5,943,399.00)($6,115,095.00)($2,911.95)N/A
10/21/2008Q3 2008($7,924,518.00)($8,003,772.00)($3,811.32)N/A
7/24/2008Q2 2008($7,528,290.00)($8,915,088.00)($4,245.28)N/A
2/20/2008Q4 2007($6,471,696.00)($14,581,119.00)($6,943.39)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 10/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.